User login
- /content/fda-oks-subcutaneous-vedolizumab-uc-maintenance-therapy
- /gihepnews/article/265648/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-uc-maintenance
- /internalmedicinenews/article/265648/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-uc
- /internalmedicine/article/265648/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-uc